Alan Louis Urban's most recent trade in GT Biopharma Inc was a trade of 50,000 Option to purchase Common Stock done . Disclosure was reported to the exchange on Sept. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GT Biopharma Inc | Alan Louis Urban | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | |
| GT Biopharma Inc | Alan Louis Urban | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | |
| GT Biopharma Inc | Alan Louis Urban | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2024 | 23,335 | 23,335 | - | - | Option to purchase Common Stock | |
| GT Biopharma Inc | Alan Louis Urban | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | |
| Research Soln Inc | Alan Louis Urban | CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.55 per share. | 20 Sep 2021 | 5,710 | 340,602 | - | 2.6 | 14,561 | Common Stock |
| Research Soln Inc | Alan Louis Urban | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 22,303 | 346,312 | - | 0 | Common Stock |